5529 related articles for article (PubMed ID: 26708682)
1. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
2. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and metabolic syndrome.
Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
[TBL] [Abstract][Full Text] [Related]
4. [Gut microbiota: Description, role and pathophysiologic implications].
Landman C; Quévrain E
Rev Med Interne; 2016 Jun; 37(6):418-23. PubMed ID: 26749318
[TBL] [Abstract][Full Text] [Related]
5. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.
Chang CJ; Lin CS; Lu CC; Martel J; Ko YF; Ojcius DM; Tseng SF; Wu TR; Chen YY; Young JD; Lai HC
Nat Commun; 2015 Jun; 6():7489. PubMed ID: 26102296
[TBL] [Abstract][Full Text] [Related]
6. The gut microbiota, obesity and insulin resistance.
Shen J; Obin MS; Zhao L
Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance.
Escobedo G; López-Ortiz E; Torres-Castro I
Rev Invest Clin; 2014; 66(5):450-9. PubMed ID: 25695388
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota and obesity.
Blaut M; Klaus S
Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
11. The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders.
Bidu C; Escoula Q; Bellenger S; Spor A; Galan M; Geissler A; Bouchot A; Dardevet D; Morio B; Cani PD; Lagrost L; Narce M; Bellenger J
Diabetes; 2018 Aug; 67(8):1512-1523. PubMed ID: 29793999
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological role of host microbiota in the development of obesity.
Kobyliak N; Virchenko O; Falalyeyeva T
Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
15. Microbiota and diabetes: an evolving relationship.
Tilg H; Moschen AR
Gut; 2014 Sep; 63(9):1513-21. PubMed ID: 24833634
[TBL] [Abstract][Full Text] [Related]
16. The Human Gut Microbiota.
Harmsen HJ; de Goffau MC
Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
[TBL] [Abstract][Full Text] [Related]
17. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
[TBL] [Abstract][Full Text] [Related]
18. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
19. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
20. Obesity, metabolic syndrome, and microbiota: multiple interactions.
Tilg H
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
